Læknablaðið : fylgirit - 01.05.1978, Blaðsíða 122

antigens have been unequivocal. Grumet & al.
found an increase in HL-A8 and W 15, but
Kissmeyer-Nielsen found no such association in
a group of 65 Danish SLE-patients^).
As to the properdin factor B phenotype deter-
minations we can not say we have found an
increase in any special Bf-phenotypes. This
field of possible association between individual
Bf-phenotypes and disease does not seem to have
been much investigated so far. Quite different
from this, of course, is the recent interest in
properdin depositions in dermal and renal lesions
in S LE-patients 12,13).
References:
1) Alper C.A. & al: Genetic polymorphism in
human glycinerich beta-glycoprotein. J. Exper.
Med. 135:68-80, 1972.
2) Alper C.A. & al: The relationship of glycine-
rich betaglycoprotein to factor B in the
properdin system and to the cobra factor-
binding protein of human serum. J. Exper.
Med. 137:424-437, 1973.
3) Cohen A.S. & al: Preliminary criteria for
the classification of systemic lupus erythema-
tosus. Bull. Rheum. Dis. 21:643-648, 1971.
4) Cohen A.S. & al: Criteria for the classifica-
tion of systemic lupus erythematosus.
Arthritis Rheum. vol 15 No 5:540-543, Sept-
Oct. 1972.
5) Dubois E.L. & al: Duration and death in
systemic lupus erythematosus. JAMA vol
227, No 12:1399-1402, March 25, 1974.
' 6) Eyrich R. & al: Systemic lupus erythema-
tosus. Incidence and manifestations during
14 years in a Swedish province. Acta med.
scand. 196:527-535, 1974.
7) Fessel W.J.: Systemic lupus erythematosus
in the community. Arch. Intern. Med.
134:1027-1035, 1974.
8) Fries J. F. & al: Estimating prognosis in
systemic lupus erythematosus. Am. J. Med.
57:561-565, Oct. 1974.
9) Kissmeyer-Nielsen F. & al. HL-A antigens
in systemic lupus erythematosus. Trans-
plantation Review 22:164-167, 197 5.
10) Lamm L. U. & al: The HL-A-types in an
Icelandic population. Histocompatibility
Testing 1972, pp 69-72, Munksgaard, Copen-
hagen, 1973.
11) Leonhardt T: Family studies in systemic
lupus erythematosus. Acta med. scand. ,
Suppl. 416, 1964.
12) Rothfield N. & al: Glomerular and dermal
deposition of properdin in systemic lupus
erythematosus. New Engl. J. Med. , vol
287, No 14:681-685, Oct. 5, 1972.
13) Schrager M.A. & al: Clinical significance
of serum properdin levels and properdin
deposition in the dermal- epidermal junction
in systemic lupus erythematosus. J. Clin.
Invest. 57-212-221, Jan. 1976.
14) Svejgaard A. & al: HL-A vævstyper og syg-
dom. Medicinsk Aarbog 1976, Munksgaard,
Copenhagen, 1976.
120